2.0(top 20%)
impact factor
14.5K(top 1%)
papers
199.7K(top 2%)
citations
144(top 2%)
h-index
2.1(top 20%)
impact factor
15.8K
all documents
211.8K
doc citations
238(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportBiology of Blood and Marrow Transplantation20053,213
2National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportBiology of Blood and Marrow Transplantation20152,636
3ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsBiology of Blood and Marrow Transplantation20191,741
4HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideBiology of Blood and Marrow Transplantation20081,525
5Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveBiology of Blood and Marrow Transplantation20091,505
6Defining the Intensity of Conditioning Regimens: Working DefinitionsBiology of Blood and Marrow Transplantation20091,419
7Chronic graft-versus-host diseaseBiology of Blood and Marrow Transplantation2003801
8Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy PatientsBiology of Blood and Marrow Transplantation2005745
9Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host DiseaseBiology of Blood and Marrow Transplantation2015619
10Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeBiology of Blood and Marrow Transplantation2010509
11First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow TransplantationBiology of Blood and Marrow Transplantation2012506
12International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International ConsortiumBiology of Blood and Marrow Transplantation2016487
13Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in HumansBiology of Blood and Marrow Transplantation2010466
14Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group ReportBiology of Blood and Marrow Transplantation2006445
15Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host DiseaseBiology of Blood and Marrow Transplantation2014444
16Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell TransplantationBiology of Blood and Marrow Transplantation2005429
17Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group ReportBiology of Blood and Marrow Transplantation2006427
18Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamideBiology of Blood and Marrow Transplantation2002413
19Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell TransplantationBiology of Blood and Marrow Transplantation2005406
20Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategiesBiology of Blood and Marrow Transplantation2003396
21Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host DiseaseBiology of Blood and Marrow Transplantation2009389
22Current Use of and Trends in Hematopoietic Cell Transplantation in the United StatesBiology of Blood and Marrow Transplantation2020378
23Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systemsBiology of Blood and Marrow Transplantation2002367
24Transplantation of ex vivo expanded cord bloodBiology of Blood and Marrow Transplantation2002356
25Multilineage differentiation activity by cells isolated from umbilical cord blood: Expression of bone, fat, and neural markersBiology of Blood and Marrow Transplantation2001354
26Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow TransplantationBiology of Blood and Marrow Transplantation2015342
27Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchBiology of Blood and Marrow Transplantation2015331
28The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseBiology of Blood and Marrow Transplantation2017328
29Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor TransplantationBiology of Blood and Marrow Transplantation2006326
30Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell TransplantationBiology of Blood and Marrow Transplantation2012324
31Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative ConditioningBiology of Blood and Marrow Transplantation2013324
32Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous TransplantationBiology of Blood and Marrow Transplantation2008319
33Pathophysiologic mechanisms of acute graft-vs.-host diseaseBiology of Blood and Marrow Transplantation1999317
34Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group ReportBiology of Blood and Marrow Transplantation2006316
35Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host DiseaseBiology of Blood and Marrow Transplantation2011311
36Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and RecommendationsBiology of Blood and Marrow Transplantation2014305
37Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic MiceBiology of Blood and Marrow Transplantation2008297
38Double Unrelated Reduced-Intensity Umbilical Cord Blood Transplantation in AdultsBiology of Blood and Marrow Transplantation2007294
39Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group ReportBiology of Blood and Marrow Transplantation2015293
40Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemiaBiology of Blood and Marrow Transplantation2001291
41Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use StudyBiology of Blood and Marrow Transplantation2011287
42Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell TherapyBiology of Blood and Marrow Transplantation2012282
43Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow TransplantationBiology of Blood and Marrow Transplantation2009278
44Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomesBiology of Blood and Marrow Transplantation2002270
45Searching for unrelated donor hematopoietic stem cells: Availability and speed of umbilical cord blood versus bone marrowBiology of Blood and Marrow Transplantation2002262
46Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on OutcomeBiology of Blood and Marrow Transplantation2010260
47Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling GraftsBiology of Blood and Marrow Transplantation2014259
48Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research StudyBiology of Blood and Marrow Transplantation2015256
49Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemiaBiology of Blood and Marrow Transplantation2003253
50Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomesBiology of Blood and Marrow Transplantation2003253